Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Regulation during Alveolar Bone Remodeling
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043810 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bowen Meng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Sun Yat-sen University, Guangzhou 510055, China. Hauptthemen laut MEDLINE: Bone Remodeling, Bone Resorption, Cell Differentiation, Osteoclasts. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China.
Abstract (Originalsprache)
Osteoimmunology mediators are critical to balance osteoblastogenesis and osteoclastogenesis to maintain bone homeostasis. A lot of the osteoimmunology mediators are regulated by interleukin-20 (IL-20). However, little is known about the role of IL-20 in bone remodeling. Here, we showed that IL-20 expression was correlated with osteoclast (OC) activity in remodeled alveolar bone during orthodontic tooth movement (OTM). Ovariectomize (OVX) in rats promoted OC activity and enhanced IL-20 expression, while blocking OC inhibited IL-20 expression in osteoclasts. In vitro, IL-20 treatment promoted survival, inhibited apoptosis of the preosteoclast at the early stages of osteoclast differentiation, and boosted the formation of osteoclasts and their bone resorption function at the late stages. More importantly, anti-IL-20 antibody treatment blocked IL-20-induced osteoclastogenesis and the subsequent bone resorption function. Mechanistically, we showed that IL-20 synergistically acts with RANKL to activate the NF-κB signaling pathway to promote the expression of c-Fos and NFATc1 to promote osteoclastogenesis. Moreover, we found that local injection of IL-20 or anti-IL-20 antibody enhanced osteoclast activity and accelerated OTM in rats, while blocking IL-20 reversed this phenomenon. This study revealed a previously unknown role of IL-20 in regulating alveolar bone remodeling and implies the application of IL-20 to accelerated OTM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Stomatology, Sun Yat-sen University, Guangzhou 510055, China.
- Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510055, China.
- South China Center of Craniofacial Stem Cell Research, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou 510055, China.
- Department of Orthodontics, Stomatological Hospital, Southern Medical University, Guangzhou 510260, China.
ORCID-Profile: Xiaoxing Kou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
Zitieren
APA
Meng, B., Yang, B., Qu, Y., Liu, Y., Wu, D., Fu, C., He, Y., Chen, X., Liu, C., Kou, X., & Cao, Y. (2023). Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Regulation during Alveolar Bone Remodeling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043810
Vancouver
Meng B, Yang B, Qu Y, Liu Y, Wu D, Fu C, et al. Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Regulation during Alveolar Bone Remodeling. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043810
BibTeX
@article{Meng2023,
author = {Meng, Bowen and Yang, Benyi and Qu, Yan and Liu, Yuanbo and Wu, Dongle and Fu, Chaoran and He, Yifan and Chen, Xi and Liu, Chufeng and Kou, Xiaoxing and Cao, Yang},
title = {Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Regulation during Alveolar Bone Remodeling},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043810}
}
EUVIMED